Sihui City in China: Create a strong engine of high-quality development with new productivity

Sihui City in China: Create a strong engine of high-quality development with new productivity

Released by Sihui City 2024-05-09 12:22 Guangdong, China

Recently, the "Zhaoqing Service Improves Every Day" Zhaoqing City Optimizing Business Environment and Promoting Private Investment Conference announced the list of Zhaoqing City's top 50 scientific and technological innovation companies in 2023. Many companies in Sihui City have successfully made the list! Yili Pharmaceutical Co., Ltd. is one of them.

Guangdong Yili Pharmaceutical Co., Ltd. is a large-scale high-tech pharmaceutical private enterprise integrating scientific research, production, sales and service.

The company and its subsidiaries currently have a total of 190 drug production approvals, involving 13 dosage forms such as capsules, tablets, mixtures, granules, syrups, etc., and produce more than 70 products year-round, mostly proprietary Chinese medicines. The products cover the treatment fields of cardiovascular and cerebrovascular disease medication, respiratory system disease medication, gynecological disease medication, pediatric medication, digestive system disease medication and other treatment areas.

Huang Canlin, General Manager of Production Center of Yili Pharmaceutical Co., Ltd.

In recent years, our company has been committed to pharmaceutical technological innovation, and the processes and technologies of many pharmaceuticals have been optimized. Our masterpiece is a new drug that has been studied for more than ten years-Huzhen Qingfeng Capsule. This drug received a national approval number in December 2021. It is a major research result of our company's technological innovation in recent years and is also a traditional Chinese medicine. The only Chinese patent medicine in the country for the treatment of gout.

Keep moving and innovate. Over the years, the company has always regarded technological innovation as its core strategy, continuously laid a solid foundation for technological innovation, and continued to increase investment in new drug research and development.

Relying on its strong R&D team and advanced technology, Yili Pharmaceutical Co., Ltd. has published 16 professional papers in various national and provincial professional journals and magazines; it has obtained 12 patent authorizations, including 2 utility model patents and 10 3 authorized invention patents, 3 of which won the 23rd and 24th China Patent Excellence Awards respectively; 6 drug regulatory production approval documents and 1 traditional Chinese medicine Category 1.1 innovative drug were approved, which is at the leading level in the country.

Huang Canlin, General Manager of Production Center of Yili Pharmaceutical Co., Ltd.

Currently, the projects we are developing include pediatric and gynecological drugs represented by Pediatric Xiangzhi Granules and Gynecological Hongjindan. These two are also innovative drugs in category 1.1 of traditional Chinese medicine and have now entered the second and third phases of clinical trials respectively.

Yili Pharmaceutical Co., Ltd. said that its successful selection into the top 50 scientific and technological innovation enterprises in Zhaoqing in 2023 is an affirmation and recognition of the company's technological innovation work over the years. Next, they will further strengthen the construction of the innovation system and continuously improve the research and development of new drugs. and industrialization level, develop more affordable good medicines for the people, and make greater contributions to the construction of "Healthy China".

Huang Canlin, General Manager of Production Center of Yili Pharmaceutical Co., Ltd.

We will take the opportunity of being selected into the top 50 scientific and technological innovation companies in Zhaoqing to further increase investment in scientific and technological innovation and research and development efforts, strive to develop more new drugs, protect the health of the people, and use scientific and technological innovation to inject strong momentum into the development of new productivity. , empowering our city’s high-quality development.

It is understood that the Sihui companies that were successfully selected into Zhaoqing's top 50 scientific and technological innovations in 2023 include Zhaoqing Delta Metal Co., Ltd., Zhaoqing Nandu Recycled Aluminum Co., Ltd., Tongyu New Materials (Guangdong) Co., Ltd., Guangdong Hong Hao Chemical Co., Ltd., Guangdong Sihui Instrument Transformer Factory Co., Ltd., Sihui Fushi Electronic Technology Co., Ltd. and Guangdong Gaodeng Aluminum Co., Ltd. and many other companies.

Innovation is the first driving force for development.

In the future, Sihui City will continue to adhere to the status of corporate innovation entities, work hard to expand the capacity and improve the quality of scientific and technological innovation entities, strive to cultivate high-quality innovative entities, transform high-level innovation results, help the echelon of innovative enterprises continue to grow, and create high-quality enterprises with new-quality productivity. A powerful engine for quality development